PTK2 and neoplasm: Focal adhesion kinase (FAK), located both in tumor cells and in the tumor microenvironment, is a non-receptor tyrosine kinase that is overexpressed in most types of cancers and plays an important role in tumor survival, angiogenesis and metastasis [5,6,7], making it a consolidated drug design target for oncological therapy and diagnosis.